Clinical Trial Update: Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating pyrotinib and vinorelbine tartrate capsules with or without inetetamab for first-line treatment in trastuzumab-resistant HE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inetetamab (inetetamab)
• Pyrotinib (pyrotinib)
• vinorelbine tartrate capsules (vinorelbine tartrate)

Snippet

Sponsor: Zhiyong Yu | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN